Skip to main content
logo
Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
9.84
-0.27 (-2.67%)
At close: Aug 28, 2026, 4:00 PM EDT
9.83
-0.02 (-0.15%)
After-hours: Aug 28, 2026, 4:10 PM EDT

Turn Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-8.45-3.19-1.77-2.29-4.29
Depreciation & Amortization
0.060.050.050.040.05
Stock-Based Compensation
10.670.350.641.88
Other Operating Activities
0.19-2.460.0100.05
Change in Accounts Payable
1.592.260.20.21-0.3
Change in Unearned Revenue
---0.021.42
Change in Other Net Operating Assets
0.060.11-0.20-0.01
Operating Cash Flow
-4.32-2.56-1.36-1.38-1.21
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Sale (Purchase) of Intangibles
-0.14-0.15-0.1-0.04-0.02
Investing Cash Flow
-0.14-0.15-0.1-0.04-0.02

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Issuance of Common Stock
4.846.921.150.50.35
Financing Cash Flow
11.566.921.150.50.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
7.14.2-0.31-0.92-0.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Levered Free Cash Flow
4.171.74-0.82-2.01-
Unlevered Free Cash Flow
4.191.74-0.82-2.01-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
1.652.37-00.231.1
SEC Filings: 10-K · 10-Q